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Among the alpha herpesviruses studied to date, the initial stage of wild-type virus attachment involves an interaction
between virally encoded structural envelope glycoproteins (predominantly glycoprotein C) and cell surface heparan sulfate
proteoglycans. An analysis of the infectious laryngotracheitis virus (ILTV) glycoprotein C and glycoprotein B sequences
suggested that these proteins lacked consensus heparin-binding domains. This indicated that ILTV might attach to its host
cell in a heparan-independent manner, distinct from other alpha herpesviruses. The infectivity of two ILTV strains, a
tissue-culture-adapted vaccine strain and a virulent field challenge strain, were found to be insensitive to the presence of
exogenous heparin or chondroitin. Furthermore, infectivity was retained in chicken embryonic liver cells treated with
heparinase. However, 4°C attachment studies and penetration studies in the presence of citrate buffer clearly demonstrated
that ILTV attaches stably to and effectively penetrates chicken embryonic liver cells. Consequently, ILTV represents an alpha
herpesvirus whose initial attachment step does not involve interactions with heparan or chondroitin sulfate containing
proteoglycans. © 1999 Academic Press
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oINTRODUCTION
Infectious laryngotracheitis virus (ILTV) is a highly con-
agious and economically significant avian alpha herpes-
irus. Some alpha herpesviruses, such as herpes sim-
lex virus (HSV-1), bovine herpesvirus type 1 (BHV-1),
nd pseudorabies virus (PRV), have broad experimental
ost ranges. ILTV has a limited host range both in vivo
nd in vitro. Natural infections are limited to galliform
irds, while embryonated eggs of turkeys and chickens
re susceptible to the virus (Hanson and Bagust, 1991).
n vitro, ILTV is efficiently propagated only on primary
hicken embryonic liver or chicken kidney cells and can
e adapted to replicate in chicken hepatocyte cell lines
Schnitzlein et al., 1994; Scholz et al., 1993).
A general scheme of herpesvirus attachment and en-
ry has been defined on the basis of studies with several
ifferent herpesviruses (Spear, 1993). Initially, these her-
esviruses utilize heparan sulfate as their primary cell
urface receptor. Heparan sulfate is commonly found on
he cell surface of eukaryotic cells and provides a net
egative charge, which enhances electrostatic binding
o a consensus basic amino acid motif found on heparin
1 Published as Paper No. 1657 in the Journal Series of the Delaware
gricultural Experiment Station.
2 Present address: Laboratory of Cellular and Molecular Biophysics,
ational Institute of Child Health and Human Development, Bethesda,
D 20892-1855.
3 To whom correspondence and reprint requests should be ad-lressed. Fax: (302) 831-2822. E-mail: ckeeler@udel.edu.
213inding proteins (Cardin and Weintraub, 1989). In herpes-
iruses, glycoprotein C (gC) homologues generally are
ound to contain such sequence motifs and are the
rimary mediators of the initial attachment step (Herold
t al., 1991; Mettenleiter et al., 1990; Okazaki et al., 1991;
awitzky et al., 1990; Tal-Singer et al., 1995). In some
erpesviruses, glycoprotein B can also bind heparan
ulfate and may provide this early attachment function in
he absence of gC (Herold et al., 1994; Li et al., 1996).
owever, work with L cell lines defective in glycosami-
oglycan biosynthesis has shown that herpesvirus infec-
ion can occur in the absence of heparan sulfate (Ban-
ield et al., 1995a). In the second stage of entry, the
lectrostatic interaction between gC and heparan sulfate
acilitates the specific interaction of glycoprotein D (gD)
ith one of several herpesvirus entry mediator proteins
Geraghty et al., 1998). HveA, a member of the tumor
ecrosis factor receptor superfamily of proteins (Mont-
omery et al., 1996; Whitbeck et al., 1997), is the HSV
eceptor on human lymphoid cells, while HveC (poliovi-
us receptor-related protein) mediates the attachment of
everal mammalian herpesviruses to a variety of cell
ypes (Geraghty et al., 1998). Finally, gB, in concert with
D, gH, and gL, mediates the pH-independent fusion of
he viral envelope to the cell membrane.
Previously, we have identified and characterized the
lycoprotein C homologue of ILTV (Kingsley et al., 1994).
omparative alignment of the ILTV gC protein with nine
ther gC proteins revealed an absence of arginine- andysine-rich sequences, a result of the apparent deletion
0042-6822/99 $30.00
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214 KINGSLEY AND KEELERf approximately 100 amino acids normally found within
he first third of the HSV-1, HSV-2, BHV-1, and PRV gC
omologues. Furthermore, the ILTV gB protein does not
ontain a consensus heparin-binding amino acid motif.
hese observations suggested that ILTV might not nor-
ally attach to cells via interactions with heparan sulfate
roteoglycans. This hypothesis was tested and con-
irmed with two strains of ILTV, a tissue culture-adapted
accine strain and a virulent challenge virus.
RESULTS
LTV attachment and penetration
To characterize the initial host cell interactions of ILTV,
ttachment assays were performed at 4°C. At 0–5°C,
iruses attach but do not penetrate susceptible cells.
herefore, the avidity of viral attachment was determined
y calculating the percentage of plaque-forming units
PFU) remaining after the infected monolayers were vig-
rously washed with PBS at 4°C. Results obtained from
xperiments with LT-IVAX (83.9%) and USDA (87.9%) were
omparable to results obtained with the PRV Becker
train (PRV-Be) (94.7%), Fig. 1A. These results indicate
hat both ILTV and PRV attach in a stable manner to
hicken embryonic liver (CEL) cells.
ILTV and PRV were also found to efficiently penetrate
EL cells at 37°C. After a 1-h adsorption period, mono-
ayers of virus-infected cells were treated with citrate
uffer as described under Materials and Methods. Ci-
rate treatment inactivates any virus remaining on the
ell surface. Therefore, plaques that form after citrate
reatment are the result of viral particles that have pen-
trated the cells. As shown in Fig. 1B, LT-IVAX and USDA
fficiently attach to cells at 37°C (84.0 and 94.0%, respec-
ively) and are also proficient at penetration (66.6 and
8.3%, respectively). The comparable attachment and
enetration values for PRV-Be were 122.9 and 72.3%.
hese results indicate that both ILTV and PRV efficiently
ttach and penetrate CEL cells at 37°C.
ttachment of ILTV in the presence of heparin sulfate
r chondroitin sulfate
The effect of exogenous heparin or chondroitin on
ttachment by the USDA and LT-IVAX strains of ILTV was
etermined and compared with PRV-Be. The effect of
hese compounds on attachment was determined by
nfecting cells with ILTV at 37°C in the presence of
arying concentrations of heparin sulfate or 70/30 chon-
roitin A/C.
Unlike PRV-Be, both LT-IVAX and the USDA strains of
LTV are relatively insensitive to the presence of heparin
Fig. 2) during adsorption, exhibiting little loss in infec-
ivity. Attachment of PRV-Be to CEL cells was blocked
95% in the presence of 5 mg/ml heparin. In contrast
oth the LT-IVAX and the USDA strains of ILTV retained at seast 83.7% of their infectivity in the presence of 5 mg/ml
f heparin. Even at 100-fold higher concentrations of
eparin (500 mg/ml) the infectivity of LT-IVAX and USDA
as reduced no more than 47.3% (data not shown). Five
undred micrograms per milliliter of heparin was not
oxic to CEL cells.
To determine whether ILTV might interact with chon-
roitin sulfate proteoglycans, as suggested for HSV-1
Banfield et al., 1995b), the effect of exogenously added
hondroitin sulfate on ILTV attachment was also as-
FIG. 1. Attachment and penetration profiles for ILTV and PRV. Attach-
ent and penetration assays were performed as described under
aterials and Methods. Strain designations are indicated beneath
ach panel. The value above each bar represents the average number
f PFU per plate, which is expressed as a percentage of the control
alue for that strain. (A) Relative attachment efficiencies of the LT-IVAX
nd USDA strains of ILTV and the Becker (PRV-Be) strain of PRV on CEL
ells after extensive PBS washing at 4°C. Error bars show the standard
eviation. (B) Relative attachment and penetration efficiencies for LT-
VAX, USDA, and PRV-Be to CEL cells after PBS washing at 37°C (solid
ars) or citrate buffer treatment at 37°C (hatched bars). Error bars show
he standard deviation.essed. As shown in Fig. 3, the USDA strain of ILTV
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215HEPARAN SULFATE-INDEPENDENT HERPESVIRUS ATTACHMENTeadily infects CEL cells in the presence of up to 500
g/ml of chondroitin sulfate.
ttachment of ILTV to heparinase treated cells
The role of heparan sulfate in herpesvirus infections
as been confirmed by experiments in which viral infec-
ivity is reduced for cells in which these surface mole-
ules have been enzymatically removed. Initially, CEL
ells were radiolabeled with [35S]sulfate and treated with
eparinase as described under Materials and Methods
n order to ensure that heparinase removes heparan
ulfate from these primary avian cells. Radiolabeled CEL
ells treated with 3 milli-international units (mIU) of hep-
rinase for 1 h released 87,600 counts per minute
cpm)/ml of 35S (42.7%), while control cells lost 21,800
pm/ml of label (7.0%) after a 1-h incubation in hepa-
inase buffer (Table 1). Similar results have been re-
orted for radiolabeled HEp-2 cells by WuDunn and
pear (1989).
CEL cells were subsequently treated with different
oncentrations of heparinase at 37°C prior to infection
ith ILTV, as described under Materials and Methods. As
hown in Fig. 4, both the LT-IVAX and the USDA strains of
LTV retained at least 80% of their infectivity on hepa-
inase treated cells. Thus, ILTV attachment is unaffected
y either the addition of exogenous heparin or chon-
roitin or the removal of heparan sulfate from the cell
urface.
DISCUSSION
A general scheme of alpha herpesvirus attachment
nd entry has been defined on the basis of studies of
SV-1, PRV, and BHV-1 (Spear, 1993). These viruses, as
ell as varicella zoster virus (Cohen and Seidel, 1994),
FIG. 2. Attachment of ILTV and PRV to CEL cells in the presence of
eparin. Heparin competition assays were performed at 37°C as de-
cribed under Materials and Methods. Values represent the average
umber of PFU per plate, expressed as a percentage of the controlmalue for that strain. n, LT-IVAX; , USDA; E, PRV-Be.uman cytomegalovirus (Compton et al., 1993), and bo-
ine herpesvirus-4 (Vanderplasschen et al., 1993), initially
ttach to their host cells via interactions with heparan
ulfate proteoglycans, which are found on the surface of
ost eukaryotic cells. Two lines of evidence support this
nitial step in herpesvirus attachment. First, enzymatic
emoval of heparan sulfate reduces the ability of HSV-1,
RV, and BHV-1 to absorb to the cell surface (Metten-
eiter et al., 1990; Okazaki et al., 1991; Sheih et al., 1992).
econd, exogenously added heparin blocks attachment
TABLE 1
Release of Heparan Sulfate Proteoglycans from CEL Cells
after Treatment with Heparinasea
Enzyme treatment
35S-labeled material released
(cpm/ml culture)
None 21,830
Heparinase (3.0 mIU) 87,670
a CEL monolayers were incubated with [35S]sulfate for 18 h and then
insed until no significant radioactivity was released. Following treat-
FIG. 3. Attachment of the USDA strain of ILTV to CEL cells in the
resence of chondroitin. Competition assays in the presence of differ-
nt concentrations of 70/30 chondroitin A/C were performed at 37°C as
escribed under Materials and Methods. The average number of PFU
er plate observed for each concentration of chondroitin sulfate, ex-
ressed as a percentage of the control value, is indicated. The error
ars show the standard deviation at each concentration.h
s
nent for 1 h at 37°C, medium was removed and counted.
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216 KINGSLEY AND KEELERy these viruses (Herold et al., 1991; Mettenleiter et al.,
990; Okazaki et al., 1991).
The first one-third of several herpesvirus gC proteins
e.g., HSV-1, PRV, and BHV-1) contains arginine- and
ysine-rich sequences that are similar to sequence mo-
ifs found in heparin binding proteins by Cardin and
eintraub (1989). The ILTV gC protein was found to lack
ot only these sequences but any extended regions of
ositive charge (Kingsley et al., 1994). This observation
orrelated with the absence of an approximately 100-
mino-acid region at the amino-terminal end of the pro-
ein. Inspection of the ILTV gB sequence also did not
eveal sequences with significant similarity to the Cardin
nd Weintraub heparin-binding motifs. In total, this sug-
ested that ILTV might not normally attach to cells via
nteractions with host cell heparan sulfate proteogly-
ans.
The relative efficiency and stability of attachment of
urified ILTV virions to CEL cells were characterized
sing 4°C attachment and 37°C attachment and pene-
ration assays. These results demonstrated that ILTV
ttaches stably to CEL cells. Virus penetration, as judged
y resistance to low pH citrate treatment after a 1-h
dsorption period at 37°C, was also efficient. However,
espite attaching to CEL cells in a stable manner, ILTV
oes not have a significant interaction with cell surface
eparan or chondroitin sulfate proteoglycans. The pres-
nce of exogenously added heparin during ILTV infection
ad limited effects on the efficiency of infection. At con-
entrations of heparin that drastically inhibit PRV infec-
ivity (5 mg/ml), ILTV strains retained significant infectivity
83.7–89.5%). Furthermore, treatment of CEL cells with
FIG. 4. Attachment of ILTV to heparinase treated CEL cells. Cells
ere treated with 0–3.0 U of heparinase for 1 h at 37°C prior to
nfection with virus, as described under Materials and Methods. Values
epresent the average number of PFU per plate, expressed as a
ercentage of the control value for that strain. n, LT-IVAX; , USDA.eparinase prior to ILTV infection did not greatly affect Mlaque formation (79–96% infectivity after treatment with
.4 mIU of heparinase). Although HSV-1 has been re-
orted to interact with chondroitin sulfate proteoglycans
n cells that lacked heparan sulfate (Banfield et al.,
995b), the presence of chondroitin A/C was also found
o have no effect on ILTV infectivity. Similar results were
btained using purified ILTV virions or total infected cell
ysates, which were sonicated before infection, as the
ource of input virus.
These results indicate that ILTV attaches to chicken
epatocytes via a chondroitin- and heparan-independent
echanism. A possible explanation for these results is
hat avian hepatocytes do not express a significant
mount of heparan sulfate on their cell surface. Enzy-
atic digestion of 35SO3-labeled CEL cells with hepa-
inase removed a significant amount of label (Table 1).
owever, although the gene for chicken syndecan, a cell
urface molecule that contains heparan sulfate, has
een cloned from LMH cells, an immortalized chicken
epatocyte cell line (Bacui et al., 1994), little is known
bout the constitution of the proteoglycans on the sur-
ace of avian cells. Indeed, differences in the processing
f avian and mammalian herpesvirus gB glycoproteins
uggest that there might also be differences in glycan
rocessing between mammalian and avian cells
Poulsen and Keeler, 1997).
Consequently, ILTV represents an alpha herpesvirus,
hose normal initial attachment phase does not involve
n electrostatic interaction with cell surface proteogly-
ans. The fact that ILTV does not utilize heparan sulfate
or attachment corroborates observations by Banfield et
l. (1995a, b) and Karger et al. (1995), which indicate that
he interaction of alpha herpesviruses with heparan sul-
ate is not an absolute requirement for virus entry. In
ddition to gB, ILTV homologues to gD (Johnson et al.,
995b), gH (C. Keeler, unpublished data), gK (Johnson et
l., 1995a), and gL (Fuchs and Mettenleiter, 1996) have
een identified. These glycoproteins are essential for
nfection by other herpesviruses. While it cannot be said
or certain what functions these proteins perform in ILTV,
heir presence suggests that the biophysical mechanism
f ILTV entry may not be fundamentally different from the
ost-heparan-binding attachment and penetration pro-
esses of the alpha herpesviruses HSV-1, HSV-2, PRV,
nd BHV-1. Unless it interacts nonspecifically with an-
ther as yet unidentified cell surface molecule, the initial
tage of ILTV attachment appears to be a direct interac-
ion with a specific cellular receptor.
It has been suggested that herpesviruses evolved
rom common precursor viruses and subsequently di-
erged by cospeciation with their respective hosts (Mc-
eoch and Cook, 1994). Based on comparative phyloge-
etic analyses, it has been suggested that ILTV has
volved separately and differs significantly from the
ammalian herpesviruses (Bagust and Johnson, 1995;
cGeoch and Cook, 1994). Assuming that heparan sul-
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217HEPARAN SULFATE-INDEPENDENT HERPESVIRUS ATTACHMENTate is not required for infection by herpesviruses, then
LTV might have evolved prior to the acquisition of this
rait. We plan to examine the role of heparan sulfate in
he initial attachment of Marek’s disease virus (MDV),
uck plague virus, and Pacheco’s disease virus, in order
o determine whether the absence of this interaction is a
rait common to avian herpesviruses. A significant por-
ion of the gC homologue of MDV, A antigen, is secreted,
uggesting that it may not be required for MDV attach-
ent.
Whether the lack of interaction of ILTV with heparan
ulfate plays a role in its limited host range remains to be
etermined. It is well established that the presence or
bsence of cell surface receptors can play a direct role
n determining host range and tissue tropism. It is pos-
ible that ILTV interacts directly with a specific receptor
n the surface of CEL cells, kidney cells, and the respi-
atory tract. Whether ILTV interacts with avian forms of
he Hve family of herpesvirus receptors (Geraghty et al.,
998; Montgomery et al., 1996; Whitbeck et al., 1997) also
emains to be determined.
MATERIALS AND METHODS
iruses
ILTV strains included LT-IVAX, a tissue-culture-
dapted vaccine strain (American Scientific Laborato-
ies, Schering Corp., Cream Ridge, NJ), and the ILTV
tandard challenge virus (USDA) (National Veterinary
ervice Laboratory, Ames, IA). Virus stocks were propa-
ated in monolayers of primary CEL cells as previously
escribed (Keeler et al., 1993). ILTV virions were purified
rom culture medium as described by Ben Porat et al.
1974). The wild-type PRV-Be strain, propagated on CEL
ells, was also used (Robbins et al., 1986).
ttachment assay
Monolayers of CEL cells on 60-mm dishes were inoc-
lated at 4°C with diluted stocks of virus. ILTV and PRV
iral stocks were diluted at 4°C to 300 PFU/ml in Dul-
ecco’s modified Eagle’s medium (DMEM) or CO2-inde-
endent medium (Life Technologies, Gaithersburg, MD)
ontaining 2% fetal bovine serum. Confluent monolayers
ere inoculated at 4°C with 150 PFU (0.5 ml) of virus.
fter 2 h, the virus inoculum was removed and the
onolayers were washed twice vigorously with cold
hosphate-buffered saline (PBS) and then overlaid with
MEM containing 2% fetal bovine serum and 1% meth-
lcellulose. Control plates were not washed, but were
mmediately overlaid with methylcellulose medium after
noculum removal. Plaques were counted 48 h postinfec-
ion. Each assay was performed in triplicate and the
verage number of plaques per plate was divided by the
verage number of plaques per plate on untreated con-rol monolayers and multiplied by 100 to determine rel- ttive attachment efficiency as a percentage of the control
alue.
enetration assay
Penetration assays were performed essentially as de-
cribed by Flynn et al. (1993). Briefly, monolayers of CEL
ells were inoculated with approximately 150 PFU of
iluted virus. After adsorption for 1 h at 37°C, virus was
emoved and plates were washed with PBS and were
reated with citrate buffer (40 mM sodium citrate, 10 mM
Cl, 135 mM NaCl, pH 3.0) for 2 min at room temperature
r were left untreated prior to being overlaid with meth-
lcellulose. Each assay was performed in triplicate. The
verage number of plaques on the PBS-washed and
itrate-treated plates was divided by the average number
f plaques on the untreated control monolayers. When
ultiplied by 100, the PBS-washed value represented the
fficiency of attachment and penetration as a percentage
f the control value, while the value for the citrate-treated
onolayers represented penetration efficiency as a per-
entage of the control value.
eparin sulfate and chondroitin sulfate competition
Heparin and chondroitin attachment competition as-
ays were performed by diluting viral stocks to a con-
entration of 150 PFU/0.5 ml in medium containing 0,
.01, 0.1, 0.5, 1.0, 5.0, 50, or 500 mg/ml heparin or 0, 1.0, 10,
00 or 500 mg/ml 70/30 chondroitin A/C (Sigma Chemical
o., St. Louis, MO). After a 2-h adsorption at 37°C,
nfected monolayers of CEL cells were gently washed
ith PBS and overlaid with methylcellulose. Plaques
ere counted 48 h postinfection. Each assay was per-
ormed in triplicate. The average number of plaques per
late was divided by the average number of plaques per
late on untreated control monolayers infected with the
ame strain and multiplied by 100 to determine relative
eparin or chondroitin resistance as a percentage of the
ontrol value.
eparinase treatment
Monolayers of CEL cells were treated with heparinase
uffer (10 mM Na2HPO4, 1.5 mM KH2PO4, 0.14 M NaCl, 3
M KCl, 0.5 mM MgCl2, 1 mM CaCl2, 0.1% glucose, 1%
etal bovine serum, 5 mg/ml ovalbumin) containing 0–3.0
IU of heparinase (ICN Biochemicals, Costa Mesa, CA)
or 1 h at 37°C. Following treatment, the monolayers
ere washed with PBS and infected with approximately
50 PFU of virus. After a 1-h adsorption at 37°C, the
nfected monolayers were washed with PBS and overlaid
ith DMEM containing 2% fetal bovine serum and 1%
ethylcellulose. Viral plaques were counted 48 h postin-
ection. The average number of plaques from the hepa-
inase-treated infections was divided by the average
umber of plaques on untreated control monolayers andhen multiplied by 100 to determine relative attachment
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218 KINGSLEY AND KEELERfficiency on heparinase-treated cells as a percentage of
he control value.
To confirm that heparinase efficiently removed hepa-
an sulfate proteoglycans from the surface of CEL cells,
ell surface proteoglycans were radiolabeled prior to
nzyme treatment, and the amount of label found in the
ulture supernatant both before and after treatment was
etermined. CEL monolayers were grown in sulfate-de-
icient DMEM medium (Life Technologies, Gaithersburg,
D) supplemented with 20 mCi/ml of [35S]sulfate for 18 h
nd washed 10 times with PBS before the addition of
eparinase buffer containing 3.0 mIU of heparinase for
h at 37°C. Each experiment was performed in triplicate
nd total incorporation of label, the amount of label
eleased after the PBS washes, and the amount of label
eleased after heparinase treatment were determined by
iquid scintillation counting.
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